Tertiary peritonitis: A disease that should not be ignored

Table 1 Adjuvant therapy in tertiary peritonitis

Microorganisms	Antimicrobial drugs	Treatment duration (for all regimens)
Gram-negative bacilli and multidrug-resistant pathogens	Meropenem or imipenem-cilastatin or piperacillin-tazobactam or doripenem; Anaerobic microorganisms: Ceftazidime or cefepime associated with metronidazole; New schemes: Ceftolozana or ceftazidime + tazobactam or avibactam; Fluorocyclines	Patients with controlled infectious focus: No more than 96 h. Patients who not yet undergone definitive control of the infectious focus: 5-7 d
Enterococcus spp	Include ampicillin or vancomycin
MRSA	Include vancomycin
Candida spp	Critical patients: Echinocandins; Patients in clinical remission: Azoles

MRSA: Methicillin-resistant Staphylococcus aureus.